JPRN-UMIN000004018招募中2 期
Phase II study of pemetrexed for advanced or relapsed non-squamous non-small-cell lung cancer in elderly patients - Phase II study of pemetrexed for advanced or relapsed non-squamous non-small-cell lung cancer in elderly patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with brain metastasis in need of steroid or anticonvulsant 2)Previous radiation therapy to primary lesion 3)History of active double cancer 4)Patients with superior vena cava syndrome 5)Uncontrollable pleural effusion, pericardial effusion or ascites 6)History of uncontrollable hypertention, diabetes mellitus, active angina pectoris, active gastrointestinal hemorrhage, recent cardiac incompetence, recent myocardial infarction, and active virus infection(except viral hepatitis) 7)Interstitial pneumonia or pulmonary fibrosis obviously detectable on chest X-ray 8)History of severe drug allergy 9)History of severe psychiatric disease 10)Patients whose participation in the trial is judged to be inappropriate by the attending doctor
研究者
相似试验
已完成
2 期
Phase II study of pemetrexed or pemetrexed plus bevacizumab for previously untreated elderly non-squamous non-small cell lung cancerJPRN-UMIN000008771ung Oncology Group in Kyushu, Japan (LOGIK)82
进行中（未招募）
1 期
Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas - N/AAdvanced/Metastatic OsteosarcomaMedDRA version: 9.1Level: PTClassification code 10031294Term: Osteosarcoma metastaticEUCTR2007-000912-97-FREli Lilly and Company Limited32
进行中（未招募）
不适用
Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas - N/AAdvanced/Metastatic OsteosarcomaMedDRA version: 9.1Level: PTClassification code 10031294Term: Osteosarcoma metastaticEUCTR2007-000912-97-GBEli Lilly and Company Limited32
进行中（未招募）
不适用
Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas - NDAdvanced/metastatic osteosarcomasMedDRA version: 9.1Level: LLTClassification code 10031294Term: Osteosarcoma metastaticEUCTR2007-000912-97-ITELI LILLY32
进行中（未招募）
不适用
Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas - N/AEUCTR2007-000912-97-DEEli Lilly and Company Limited32